Kaiser Permanente-San Rafael

Summary

Kaiser Permanente-San Rafael is a medical facility located in San Rafael, California. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer, Colorectal Cancer and other specialties. Kaiser Permanente-San Rafael is involved with conducting 150 clinical trials across 285 conditions. There are 4 research doctors associated with this hospital, such as Jennifer M. Suga, Tatjana Kolevska, MD, Samantha A. Seaward, and Ramey D. Littell.

Top PIs

Clinical Trials running at Kaiser Permanente-San Rafael

Brain Tumor

Cardiotoxicity

Breast cancer

Meningioma

Breast Cancer

Brain Metastasis

HER2 Positive

Non-Small Cell Lung Cancer

Neurofibromatosis

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.

Recruiting

2 awards

Phase 3

23 criteria

Multiple Targeted Therapies

for Meningioma

This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.

Recruiting

1 award

Phase 2

10 criteria